
Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …

Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …

